Obtained M.Sc(BioOrganic Chemistry) from Gulbarga University(1986) and PhD (Bioorganic Chemistry) from Indian Institute of Chemical Technology, Hyderabad(1995)/Osmania Univeristy.
Worked as Alexander von Humboldt guest researcher at Fredrick Alexander Univerisity, Erlangen , Germany (2019) on anticancer hybrid drugs.
Earlier he worked in Max Planck Institute of Dortmund as Alexander von Humboldt Fellow in the area of gene therapy(2000).
Worked on agrochemical and pharmaceutical technology development and his sustained efforts led to the development of cost effective process know how for important drugs such as Sulbactam and agrochemicals like Lambda Cyhalothrin, Cypermethrin which are commercialized in India based on CSIR-IICT technology.
Developed novel skin care hybrid molecules and worked on major collaborative projects with P&G and Colgate-Palmolive, on oral and skin care product
Worked on the development and plant based novel Vaccine adjuvants (Bharat Biotech Intl Ltd.)
Had been the Chairman of Synthetic and biological chemistry division(presently medicinal chemistry and chemical biology department) at CSIR-IIIM 2007 - 2009.) At CSIR-IICT,
Focus of current research ; development of, novel small molecule immunomodulators, vaccine(Th1) adjuvants, peptide epitope based synthetic vaccines
Topics of his interest include, minimum cosmeceuticals employing hybrid skin care technologies. Medicinal Chemistry and drug design, ,